医药和健康-文传商讯-中国领先的企业新闻稿

欢迎访问文传商讯！

文传商讯

行业分类

高科技金融通信和传媒金属和矿产制造业化工医药和健康建筑和房地产旅游教育生活和娱乐能源和环境汽车体育贸易运输和物流企业社会责任

当前行业：医药和健康

[2017-11-20 09:50]

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases

.

[2017-11-20 09:48]

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer

.

[2017-11-17 10:15]

Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation from FDA and Prime Eligibility from EMA for Relapsed and Refractory Multiple Myeloma

.

[2017-11-17 10:07]

AstraZeneca to Present Transformative Data at ESMO Asia 2017 Congress from Pivotal Trials Showing Potential New Standards of Care in Non-small Cell Lung Cancer

.

[2017-11-16 15:27]

武田的ADCETRIS (brentuximab vedotin)获得CHMP肯定意见，用于治疗CD30阳性皮肤T细胞淋巴瘤

.

[2017-11-16 15:00]

寰宇保险代理被安盛天平评为中国最佳保险代理

.

[2017-11-16 09:54]

Faslodex (Fulvestrant) Receives EU Approval for the Treatment of Hormone Receptor-Positive Advanced Breast Cancer in Combination with Palbociclib1

.

[2017-11-15 17:38]

Key sub-analyses of RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa™ (dabigatran etexilate) dual therapy was used instead of warfarin triple therapy

.

[2017-11-14 19:28]

New RE-VERSE AD™ analyses provide additional insights on impact of Praxbind® (idarucizumab) in Pradaxa® (dabigatran etexilate) patients with gastrointestinal bleeding or needing emergency surgery

.

[2017-11-14 19:23]

Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease

.

[2017-11-14 10:09]

Cyltezo, adalimumab biosimilar from Boehringer Ingelheim, approved in Europe for the treatment of multiple chronic inflammatory diseases

.

[2017-11-13 10:03]

SCIEX宣布与浙江迪安诊断技术股份有限公司在中国建立合资企业

.

[2017-11-10 15:06]

患者安全运动基金会与欧洲麻醉学会联合召开世界峰会

.

[2017-11-10 11:50]

患者安全运动基金会与迪拜卫生署启动中东首次患者安全运动

.

[2017-11-10 09:54]

Alexion Employees Volunteer Together to Enhance Their Local Communities during Second Annual Global Day of Service

.

[2017-11-09 09:56]

Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases

.

[2017-11-08 14:11]

Progenity宣布完成1.25亿美元融资，用于产前-女性健康遗传学和胃肠病/炎性肠病精准医学

.

[2017-11-07 09:51]

Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents; New 18-Month Interim Phase 2 Data Published in The Lancet Infectious Diseases

.

[2017-11-07 09:49]

Efficacy and safety maintained in patients who switched from Humira to biosimilar Cyltezo

.

[2017-11-06 18:32]

武田在美国血液学会第59届年会上呈报的数据有望重塑血液肿瘤治疗的未来

.

[2017-11-03 09:48]

Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)

.

[2017-11-03 09:46]

Philip Morris International Outlines Its Scientific Assessment Program and Results for Its Electronically Heated Tobacco Product (IQOS) in Latest Scientific Update for Smoke-Free Products

.

[2017-11-02 18:37]

武田药品工业株式会社公布2017年上半年业绩

.

[2017-11-02 13:55]

PMC Group International宣布收购印度制药公司

.

[2017-11-02 11:29]

2017企业健康管理高峰论坛将于11月16日在沪召开

.

[2017-10-31 15:34]

GRAMINEX L.L.C.在临床研究发表后扩大与IDIPharma的伙伴关系

.

[2017-10-31 09:54]

Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy

.

[2017-10-30 10:51]

Efficacy and Safety Results from Second Phase III Trial (RADIANCE Part B) of Oral Ozanimod Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting

.

[2017-10-30 10:43]

Efficacy and Safety Results from First Phase III Trial of Oral Ozanimod (SUNBEAM) Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting

.

[2017-10-26 09:44]

Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA Shows Positive Outcome in Treatment of Antiretroviral-Nave HIV Patients

.

[2017-10-20 09:34]

Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting

.

[2017-10-17 15:40]

武田呈报ALUNBRIGTM (brigatinib)治疗ALK阳性非小细胞肺癌枢纽性2期ALTA试验的更新结果

.

[2017-10-17 09:50]

AstraZeneca and Chi-Med’s Savolitinib Shows Encouraging Clinical Activity in 2nd-Line EGFR Mutation-positive Lung Cancer with MET-amplification

.

[2017-10-17 09:48]

Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017

.

[2017-10-16 10:02]

康寶萊亞太區健康老化調查顯示，亞太地區消費者擔憂老化相關的健康問題，但低估了營養在健康老化中的重要性

.

[2017-10-16 09:58]

FASLODEX (FULVESTRANT) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER IN COMBINATION WITH PALBOCICLIB1

.

[2017-10-12 12:48]

和铂医药宣布，已授权信达生物制药使用其全人源单克隆抗体转基因小鼠平台开发多种全人源单克隆抗体新药

.

[2017-10-11 15:00]

美国FDA批准健能隆F-627用于治疗化疗导致的嗜中性粒细胞减少症的国际III期临床使用“特殊方案评估”

.

[2017-10-11 10:15]

Ferring Strengthens Growth Hormone Franchise Zomacton Through Acquisition of ZomaJet Needle-Free Injector Device

.

[2017-10-11 09:45]

请饮用世界上最完美的咖啡GlycoCafé醣质咖啡

.

[2017-10-09 14:47]

居家医疗保健 – 京都大学创新中心和松下开发的雷达健康监护仪获得重大升级

.

[2017-10-09 13:51]

2017企业健康管理高峰论坛将于11月16日在沪召开

.

[2017-10-09 10:20]

Seattle Genetics and Takeda Announce Publication in Blood of Final Long-Term Survival Data from ADCETRIS (Brentuximab Vedotin) Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

.

[2017-10-09 10:00]

Ferring Appoints Klaus Dugi as Executive Vice President and Chief Medical Officer

.

[2017-09-29 17:30]

武田在第18届世界肺癌大会上呈报通过枢纽性2期ALTA 临床试验获得的ALUNBRIG™ (brigatinib)数据

.

[2017-09-29 09:43]

Replicor宣布其针对HBV/HDV合并感染的REP 301研究已在《柳叶刀肠胃病学和肝病学》上发表

.

[2017-09-28 20:00]

粉红丝带创立25周年：雅诗兰黛公司发起的防治乳腺癌运动迎来25周年里程碑

.

[2017-09-28 10:36]

开放式创新 · 战略式合作 —— 2017亚太生物医药合作峰会圆满落下帷幕

.

[2017-09-27 14:49]

22nd Century与英美烟草之间的限制性许可协议终止

.

[2017-09-27 09:45]

European Commission Approves Symtuza for the Treatment of HIV-1 In Adults and Adolescents in Europe

.

媒体合作

xinhua08

takungpao

China.com

C114.net

中国能源网

证券之星

金融界

中金在线

天和网

中国金融网

中汽传媒

中国环保网

百歌新闻专线

亚洲商机

中国智能卡论坛

广西物流网

品牌世家

中国电子标签网

360教育在线

21世纪保险网

中国能源投资网

中国电子商业联盟

中国汽车咨询中心网

煤炭供应链

美国证券网

百奥知

CTI论坛

中国测控网

北极星电力网

福建之窗

智库在线

电脑商情在线

赢商网

湖南信息港

赢在中国网

比邻星环保网

中国制造业门户

i美股

百年企业在线

第一车市汽车网

中国西部网

© 2024 文传商讯
设为首页- 加入收藏 - 简繁转换 - 联系我们